Candriam SCA’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-405,751
| Closed | -$7.5M | – | 688 |
|
|
2024
Q1 | $7.5M | Buy |
+405,751
| New | +$7.5M | 0.05% | 289 |
|
|
2022
Q2 | – | Sell |
-230,417
| Closed | -$5.58M | – | 775 |
|
|
2022
Q1 | $5.58M | Sell |
230,417
-45,143
| -16% | -$1.09M | 0.04% | 330 |
|
|
2021
Q4 | $6.43M | Hold |
275,560
| – | – | 0.04% | 311 |
|
|
2021
Q3 | $4.58M | Hold |
275,560
| – | – | 0.03% | 415 |
|
|
2021
Q2 | $6.72M | Sell |
275,560
-23,328
| -8% | -$569K | 0.05% | 350 |
|
|
2021
Q1 | $15.3M | Hold |
298,888
| – | – | 0.13% | 179 |
|
|
2020
Q4 | $16M | Sell |
298,888
-10,112
| -3% | -$541K | 0.13% | 181 |
|
|
2020
Q3 | $12.7M | Buy |
309,000
+70,000
| +29% | +$2.89M | 0.12% | 189 |
|
|
2020
Q2 | $11.6M | Buy |
239,000
+159,000
| +199% | +$7.71M | 0.12% | 195 |
|
|
2020
Q1 | $3.35M | Hold |
80,000
| – | – | 0.04% | 445 |
|
|
2019
Q4 | $3.42M | Buy |
+80,000
| New | +$3.42M | 0.04% | 459 |
|
|
2019
Q1 | – | Sell |
-173,700
| Closed | -$2.81M | – | 789 |
|
|
2018
Q4 | $2.81M | Buy |
173,700
+38,000
| +28% | +$615K | 0.04% | 390 |
|
|
2018
Q3 | $2.82M | Buy |
135,700
+3,700
| +3% | +$76.8K | 0.04% | 426 |
|
|
2018
Q2 | $2.02M | Buy |
132,000
+55,000
| +71% | +$840K | 0.03% | 483 |
|
|
2018
Q1 | $1.73M | Hold |
77,000
| – | – | 0.03% | 507 |
|
|
2017
Q4 | $2.32M | Hold |
77,000
| – | – | 0.04% | 428 |
|
|
2017
Q3 | $2.9M | Sell |
77,000
-50,000
| -39% | -$1.88M | 0.05% | 377 |
|
|
2017
Q2 | $3.54M | Buy |
127,000
+66,000
| +108% | +$1.84M | 0.07% | 339 |
|
|
2017
Q1 | $2.1M | Buy |
+61,000
| New | +$2.1M | 0.04% | 431 |
|
|
2015
Q4 | – | Sell |
-93,200
| Closed | -$3.08M | – | 557 |
|
|
2015
Q3 | $3.08M | Sell |
93,200
-48,800
| -34% | -$1.61M | 0.08% | 273 |
|
|
2015
Q2 | $5.95M | Sell |
142,000
-11,000
| -7% | -$461K | 0.12% | 209 |
|
|
2015
Q1 | $4.99M | Sell |
153,000
-12,000
| -7% | -$391K | 0.1% | 254 |
|
|
2014
Q4 | $5.24M | Buy |
+165,000
| New | +$5.24M | 0.11% | 221 |
|